Category: Medical
New Crohn’s Treatment Shows Promise for True Healing
New clinical trial results show risankizumab achieving 52% remission rates and actual tissue healing in Crohn’s patients. This breakthrough suggests we may be moving beyond symptom management toward true intestinal repair.
The Hidden Cost of Waiting: Why IBD Diagnosis Delays Matter
New research reveals that delays in IBD diagnosis lead to worse health outcomes, including increased need for surgery and complications. Understanding this connection can help current patients advocate for faster diagnosis and appropriate care.
New Hope: Revolutionary Crohn’s Therapy Enters Clinical Trials
Researchers at the Hudson Institute have developed a groundbreaking therapy for perianal Crohn’s disease using extracellular vesicles that could sidestep the cost and accessibility challenges of traditional stem cell treatments. This innovative approach has entered clinical trials, offering new hope for patients with one of IBD’s most challenging manifestations.
New Hope for Perianal Crohn’s: Upadacitinib Shows Promise
New research shows upadacitinib may offer hope for perianal fistulizing Crohn’s disease, with nearly half of patients achieving clinical remission after 24 weeks. This breakthrough represents meaningful progress for those who haven’t found relief with traditional treatments.
New Entyvio Biosimilar Could Mean Big Savings for IBD Patients
A new partnership aims to bring an Entyvio biosimilar to market, potentially offering IBD patients more affordable access to this important treatment. Here’s what this development could mean for our community and your treatment options.
New Hope for Kids with IBD: Oral Vancomycin Shows Promise
Recent research shows promising results for children with IBD treated with oral vancomycin, with significant improvements in symptoms and disease markers. While preliminary, this study offers hope for families seeking new treatment approaches for pediatric IBD.
Sara Levitt Shows Crohn’s Won’t Stop Her Miss Universe Dream
Miss Universe Canada contestant Sara Levitt is showing the world that Crohn’s disease won’t stop her from achieving her dreams. Her openness about living with IBD is creating powerful representation for our community and changing perceptions about what’s possible with chronic illness.
